Swedish medtech making a medically-approved tDCS device and app to treat depression.
| Date | Round | Amount |
|---|---|---|
| Aug 2021 | Series A Swedish medtech Flow Neuroscience closed a $9m Series A led by Khosla Ventures, Swiss Health Ventures and Zühlke Ventures, to bring its depression-treatment headset to the US. | $9M |